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Purpose
The main outcome of virus-related hepatitis is progression to liver fibrosis. Then, early diagnosis is very important in treatment and management of patients. Although liver biopsy is the gold standard test for assessment of liver fibrosis, it is expensive and has some disadvantages such as sampling errors, interobserver variability and significant mortality and morbidity rate. On the other hand, this method is invasive and has side effects, especially if it needs to repeat sampling. Finding a reliable non-invasive modality instead of biopsy, we studied the value of gray scale and Doppler ultrsonography for the diagnosis of liver fibrosis in patients with chronic viral hepatitis.
We designed this study to evaluate the diagnostic value to conventional and Doppler ultrasound findings in liver fibrosis of patients with chronic viral hepatitis and to compare it with the pathological grading results of such patients.
Methods and Materials
Between Jan 2008 to Feb 2010, 60 patients with chronic hepatitis B (n=43) and C (n=14) who were candidated for liver biopsy in the liver department of Imam Reza teaching hospital were enrolled. All patients had a positive serum HBsAg or Anti-HCV antibody along with abnormal serum alanine transaminase level in the past six months. Patients with clinical and/or biochemical evidence of decompensated hepatic function or portal hypertension; and known hepatic disease of other etiology were excluded from the study.
Our study was approved by the ethic committee of Mashhad University of Medical Sciences (No: 87543). All patients signed informed consents. Gray scale and Duplex ultrasonography (DS) were performed for all patients during the week before liver biopsy.
Ultrasonographic findings were recorded according to an US scoring system and compared with histological finding after liver biopsy.
Results
35 male (mean age: 36/1±10/1 years) and 25 female (mean age: 36/1± 10/04 years) were studied. 43 patients had chronic hepatitis B and others had chronic hepatitis C.
Overall gray scale US score was abnormal (ranged from 1 to 7) in 63.3% of patients and normal (zero) in the others. ( Table 1 ). ( Fig.2,3) score (Fig. 1) Total DS score was abnormal (1 or 2) in 66.7% of patients. Quantitative US parameters, related more significantly with the histopathologic staging scores of liver fibrosis, were: portal vein mean velocity, right hepatic vein diameter and gallbladder wall thickness. Total gray scale US score, DS score and accumulation of US and DS scores (US-DS score) were significantly different between patients with liver fibrosis and those without fibrosis (P=0.03, P =0.03 and P<0.001 ) . We found a significant correlation between Total Gray scale US score, DS score and US-DS score with liver fibrosis stages.
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Conclusion
Since there was a significant correlation between Toral Gray scale Us score, DS score and US-DS score with liver fibrosis, ultrsonography might be an accurate, non-invasive alternative modality for diagnosis of liver fibrosis with less side effects than biopsy. It may be especially useful for repetitive follow up of the patients.
